Provided by Tiger Fintech (Singapore) Pte. Ltd.

Contineum Therapeutics, INC.

7.49
+0.43006.09%
Post-market: 7.490.00000.00%16:02 EDT
Volume:145.66K
Turnover:1.04M
Market Cap:193.08M
PE:-3.49
High:7.53
Open:7.00
Low:6.73
Close:7.06
Loading ...

Contineum Completes Enrollment in Trial for Relapsing-Remitting Multiple Sclerosis Treatment

MT Newswires Live
·
09 Jan

BRIEF-Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Reuters
·
09 Jan

Contineum Therapeutics Completes Enrollment in Phase 2 Pipe-307 Vista Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (Rrms)

THOMSON REUTERS
·
09 Jan

BRIEF-Rapt Therapeutics Names Lori Lyons-Williams Chair Of The Board

Reuters
·
06 Jan

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors

THOMSON REUTERS
·
06 Jan

RAPT Therapeutics Inc - William Rieflin Steps Down as Chair, Remains Consultant

THOMSON REUTERS
·
06 Jan

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors

GlobeNewswire
·
06 Jan

Top Premarket Decliners

MT Newswires Live
·
27 Dec 2024

Contineum Starts Patient Dosing in Positron Emission Tomography Trial

MT Newswires Live
·
17 Dec 2024

BRIEF-Contineum Therapeutics Initiates Patient Dosing In Phase 1B Positron Emission Tomography (Pet) Trial Of Pipe-791

Reuters
·
17 Dec 2024

Contineum initiates patient dosing in Phase 1B PET trial

TIPRANKS
·
17 Dec 2024

Contineum Therapeutics Initiates Patient Dosing in Phase 1B Positron Emission Tomography (Pet) Trial of Pipe-791

THOMSON REUTERS
·
17 Dec 2024

Contineum Therapeutics Inc - Doses First Cohort in Pipe-791 Phase 1B Trial

THOMSON REUTERS
·
17 Dec 2024

Contineum Therapeutics Inc - Anticipates Topline Data From Pipe-791 Trial in Q2 2025

THOMSON REUTERS
·
17 Dec 2024

Contineum Therapeutics Inc - Topline Data Readout Expected in Q2 2025

THOMSON REUTERS
·
17 Dec 2024

Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791

Business Wire
·
17 Dec 2024